Complex single gene disorders and epilepsy

Epilepsia

Volumn 53, Issue SUPPL. 4, 2012, Pages 81-91

  Merwick, Aine ^a   O'Brien, Margaret ^a   Delanty, Norman ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

Complex disorders; Epil epsy; Genetic

Indexed keywords

ARTICLE; CLINICAL FEATURE; DISEASE COURSE; EPILEPSY; GENE MUTATION; GENETIC SCREENING; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MEDICAL LITERATURE; MYOCLONUS EPILEPSY; PRIORITY JOURNAL; RETT SYNDROME; TUBEROUS SCLEROSIS; TUBEROUS SCLEROSIS COMPLEX;

ANGELMAN SYNDROME; CADHERINS; CLASSICAL LISSENCEPHALIES AND SUBCORTICAL BAND HETEROTOPIAS; EPILEPSY; GENETIC DISEASES, INBORN; GENETIC DISEASES, X-LINKED; HUMANS; LAFORA DISEASE; MERRF SYNDROME; NEUROFIBROMATOSES; RETT SYNDROME; TUBEROUS SCLEROSIS; UNVERRICHT-LUNDBORG SYNDROME;

EID: 84865707720     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2012.03617.x     Document Type: Article

References (113)

1. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY,. (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl- CpG-binding protein 2. Nat Genet 23: 185-188. (Pubitemid 29455390)
2. Angelman H,. (1965) Puppet children: a report of three cases. Dev Med Child Neurol 7: 681-688.
3. Archer HL, Whatley SD, Evans JC, Ravine D, Huppke P, Kerr A, Bunyan D, Kerr B, Sweeney E, Davies SJ, Reardon W, Horn J, MacDermot KD, Smith RA, Magee A, Donaldson A, Crow Y, Hermon G, Miedzybrodzka Z, Cooper DN, Lazarou L, Butler R, Sampson J, Pilz DT, Laccone F, Clarke AJ,. (2006) Gross rearrangements of the MECP2 gene are found in both classical and atypical Rett syndrome patients. J Med Genet 43: 451-456.
4. Ariani F, Hayek G, Rondinella D, Artuso R, Mencarelli MA, Spanhol-Rosseto A, Pollazzon M, Buoni S, Spiga O, Ricciardi S, Meloni I, Longo I, Mari F, Broccoli V, Zappella M, Renieri A,. (2008) FOXG1 is responsible for the congenital variant of Rett syndrome. Am J Hum Genet 83: 89-93.
5. Astrinidis A, Senapedis W, Coleman TR, Henske EP,. (2003) Cell cycle-regulated phosphorylation of hamartin, the product of the tuberous sclerosis complex 1 gene, by cyclin-dependent kinase 1/cyclin B. J Biol Chem 278: 51372-51379. (Pubitemid 38020376)
6. Au KS, Hebert AA, Roach ES, Northrup H,. (1999) Complete inactivation of the TSC2 gene leads to formation of hamartomas. Am J Hum Genet 65: 1790.
7. Au KS, Williams AT, Gambello MJ, Northrup H,. (2004) Molecular genetic basis of tuberous sclerosis complex: from bench to bedside. J Child Neurol 19: 699-709. (Pubitemid 39530080)
8. Au KS, Williams AT, Roach ES, Batchelor L, Sparagana SP, Delgado MR, Wheless JW, Baumgartner JE, Roa BB, Wilson CM, Smith-Knuppel TK, Cheung MY, Whittemore VH, King TM, Northrup H,. (2007) Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States. Genet Med 9: 88-100.
9. Avellino AM, Berger MS, Rostomily RC, Shaw CM, Ojemann GA,. (1997) Surgical management and seizure outcome in patients with tuberous sclerosis. J Neurosurg 87: 391-396. (Pubitemid 27362571)
10. Baumgartner JE, Wheless JW, Kulkarni S, Northrup H, Au KS, Smith A, Brookshire B,. (1997) On the surgical treatment of refractory epilepsy in tuberous sclerosis complex. Pediatr Neurosurg 27: 311-318. (Pubitemid 28257402)
11. Bombardieri R, Pinci M, Moavero R, Cerminara C, Curatolo P,. (2010) Early control of seizures improves long-term outcome in children with tuberous sclerosis complex. Eur J Paediatr Neurol 14: 146-149.
12. Bonneau D, Toutain A, Laquerrière A, Marret S, Saugier-Veber P, Barthez MA, Radi S, Biran-Mucignat V, Rodriguez D, Gélot A,. (2002) X-linked lissencephaly with absent corpus callosum and ambiguous genitalia(XLAG): clinical, magnetic resonance imaging, and neuropathological findings. Ann Neurol 51: 340-349. (Pubitemid 34206290)
13. Camposano SE, Major P, Halpern E, Thiele EA,. (2008) Vigabatrin in the treatment of childhood epilepsy: a retrospective chart review of efficacy and safety profile. Epilepsia 49: 1186-1191. (Pubitemid 351991397)
14. Chan EM, Young EJ, Ianzano L, Munteanu I, Zhao X, Christopoulos CC, Avanzini G, Elia M, Ackerley CA, Jovic NJ, Bohlega S, Andermann E, Rouleau GA, Delgado-Escueta AV, Minassian BA, Scherer SW,. (2003) Mutations in NHLRC1 cause progressive myoclonus epilepsy. Nat Genet Oct 35: 125-127. (Pubitemid 37187629)
15. Chu-Shore CJ, Major P, Montenegro M, Thiele E,. (2009) Cyst-like tubers are associated with TSC2 and epilepsy in tuberous sclerosis complex. Neurology 72: 1165.
16. Chu-Shore CJ, Major P, Camposano S, Muzykewicz D, Thiele EA,. (2010) The natural history of epilepsy in tuberous sclerosis complex. Epilepsia 51: 1236.
17. Cossée M, Faivre L, Philippe C, Hichri H, de Saint-Martin A, Laugel V, Bahi-Buisson N, Lemaitre JF, Leheup B, Delobel B, Demeer B, Poirier K, Biancalana V, Pinoit JM, Julia S, Chelly J, Devys D, Mandel JL,. (2011) ARX polyalanine expansions are highly implicated in familial cases of mental retardation with infantile epilepsy and/or hand dystonia. Am J Med Genet A 155A: 98-105.
18. Crino P, Nathanson K, Henske E,. (2006) The tuberous sclerosis complex. N Engl J Med 355: 1345-1356.
19. Curatolo P, Bombardieri R, Joswiak S,. (2008a) Tuberous sclerosis. Lancet 372: 657-668.
20. Cusmai R, Chiron C, Curatolo P, Dulac O, Tran-Dinh S,. (1990) Topographic comparative Study of magnetic resonance imaging and electroencephalography in 34 children with tuberous sclerosis. Epilepsia 31: 747-755.
21. Dabora SL, Jozwiak S, Franz DN, Roberts PS, Nieto A, Chung J, Choy YS, Reeve MP, Thiele E, Egelhoff JC, Kasprzyk-Obara J, Domanska-Pakiela D, Kwiatkowski DJ,. (2001) Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet 68: 64-80. (Pubitemid 32048362)
22. Dayer AG, Bottani A, Bouchardy I, Fluss J, Antonarakis SE, Haenggeli CA, Morris MA,. (2007) MECP2 mutant allele in a boy with Rett syndrome and his unaffected heterozygous mother. Brain Dev 29: 47-50. (Pubitemid 46073552)
23. Depienne C, LeGuern E,. (2012) PCDH19-related infantile epileptic encephalopathy: an unusual X-linked inheritance disorder. Hum Mutat 33: 627-634.
24. Dibbens LM, Tarpey PS, Hynes K, Bayly MA, Scheffer IE, Smith R, Bomar J, Sutton E, Vandeleur L, Shoubridge C, Edkins S, Turner SJ, Stevens C, O'Meara S, Tofts C, Barthorpe S, Buck G, Cole J, Halliday K, Jones D, Lee R, Madison M, Mironenko T, Varian J, West S, Widaa S, Wray P, Teague J, Dicks E, Butler A, Menzies A, Jenkinson A, Shepherd R, Gusella JF, Afawi Z, Mazarib A, Neufeld MY, Kivity S, Lev D, Lerman-Sagie T, Korczyn AD, Derry CP, Sutherland GR, Friend K, Shaw M, Corbett M, Kim HG, Geschwind DH, Thomas P, Haan E, Ryan S, McKee S, Berkovic SF, Futreal PA, Stratton MR, Mulley JC, Gécz J,. (2008) X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment. Nat Genet. Jun 40: 776-781. (Pubitemid 351748867)
25. Downs J, Young D, de Klerk N, Bebbington A, Baikie G, Leonard H,. (2009) Impact of scoliosis surgery on activities of daily living in females with Rett syndrome. J Pediatr Orthop 29: 369-374.
26. El-Hashemite N, Zhang H, Henske EP, Kwiatkowski DJ,. (2003) Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma. Lancet 361: 1348.
27. Elliott RE, Carlson C, Kalhorn SP, Moshel YA, Weiner HL, Devinsky O, Doyle WK,. (2009) Refractory epilepsy in tuberous sclerosis: vagus nerve stimulation with or without subsequent resective surgery. Epilepsy Behav; 16: 454.
28. Emond MR, Biswas S, Blevins CJ, Jontes JD,. (2011) A complex of Protocadherin-19 and N-cadherin mediates a novel mechanism of cell adhesion. J Cell Biol 195: 1115-1121.
29. European Chromosome 16 Tuberous Sclerosis Consortium. (1993) Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75: 1305.
30. Evans DG,. (2009) Neurofibromatosis type 2 (NF2): a clinical and molecular review. Orphanet J Rare Dis 4: 16.
31. Evans DG, Huson SM, Donnai D, Neary W, Blair V, Newton V, Harris R,. (1992) A clinical study of type 2 neurofibromatosis. Q J Med 84: 603-618. (Pubitemid 23007763)
32. Evans DG, Ramsden RT, Shenton A, Gokhale C, Bowers NL, Huson SM, Pichert G, Wallace A,. (2007) Mosaicism in neurofibromatosis type 2: an update of risk based on uni/bilaterality of vestibular schwannoma at presentation and sensitive mutation analysis including multiple ligation-dependent probe amplification. J Med Genet 44: 424-428. (Pubitemid 47056867)
33. Ferlazzo E, Magaudda A, Striano P, Vi-Hong N, Serra S, Genton P,. (2007) Long-term evolution of EEG in Unverricht-Lundborg disease. Epilepsy Res 73: 219-227.
34. Franceschetti S, Antozzi C, Binelli S, Carrara F, Nardocci N, Zeviani M, Avanzini G,. (1993) Progressive myoclonus epilepsies: an electroclinical, biochemical, morphological and molecular genetic study of 17 cases. Acta Neurol Scand 87: 219-223. (Pubitemid 23089919)
35. Franz DN, Leonard J, Tudor C, Chuck G, Care M, Sethuraman G, Dinopoulos A, Thomas G, Crone KR,. (2006) Rapamycin causes regression of astrocytomas in tuberous sclerosis complex. Ann Neurol 59: 490-498. (Pubitemid 43358069)
36. Friedman JM,. (1999) Vascular and endocrine abnormalities. In:, Friedman JM, Gutmann DH, MacCollin M, Riccardi VM, (Eds) Neurofibromatosis. Phenotype, Natural History, and Pathogenesis. Johns Hopkins University Press, Baltimore, pp. 274-296.
37. Friedman JM, Birch PH,. (1997) Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients. Am J Med Genet 70: 138-143. (Pubitemid 27184570)
38. Friez MJ, Jones JR, Clarkson K, Lubs H, Abuelo D, Bier JA, Pai S, Simensen R, Williams C, Giampietro PF, Schwartz CE, Stevenson RE,. (2006) Recurrent infections, hypotonia, and mental retardation caused by duplication of MECP2 and adjacent region in Xq28. Pediatrics 118: e1687-e1695. (Pubitemid 46397542)
39. Friocourt G, Parnavelas JG,. (2010) Mutations in ARX result in several defects involving GABAergic neurons. Front Cell Neurosci 11: 4.
40. Fukuda T, Yamashita Y, Nagamitsu S, Miyamoto K, Jin JJ, Ohmori I, Ohtsuka Y, Kuwajima K, Endo S, Iwai T, Yamagata H, Tabara Y, Miki T, Matsuishi T, Kondo I,. (2005) Methyl-CpG binding protein 2 gene (MECP2) variations in Japanese patients with Rett syndrome: pathological mutations and polymorphisms. Brain Dev 27: 211-217. (Pubitemid 40320470)
41. Gomez MR,. (2003) Neurological and psychiatric features. In:, Gomez MR, (Ed) Tuberous sclerosis. Raven Press, New York, pp. 21-68.
42. Hagberg B, Hanefeld F, Percy A, Skjeldal O,. (2002) An update on clinically applicable diagnostic criteria in Rett syndrome: comments to Rett Syndrome Clinical Criteria Consensus Panel Satellite to European Paediatric Neurology Society Meeting, Baden Baden, Germany, 11 September 2001. Eur J Paediatr Neurol 6: 293-297. (Pubitemid 36267302)
43. Han JM, Sahin M,. (2011) TSC1/TSC2 signaling in the CNS. FEBS Lett 585: 973-980.
44. Italiano D, Pezzella M, Coppola A, Magaudda A, Ferlazzo E, Bramanti P, Striano S, Zara F, Striano P,. (2011) A pilot open-label trial of zonisamide in Unverricht-Lundborg disease. Mov Disord 26: 341-343.
45. Jaenisch R, Bird A,. (2003) Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33 (Suppl): 245-254. (Pubitemid 36278835)
46. Jansen FE, van Huffelen AC, Algra A, van Nieuwenhuizen O,. (2007) Epilepsy surgery in tuberous sclerosis: a systematic review. Epilepsia 48: 1477.
47. Jones AC, Shyamsundar MM, Thomas MW, Maynard J, Idziaszczyk S, Tomkins S, Sampson JR, Cheadle JP,. (1999) Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis. Am J Hum Genet 64: 1305-1315. (Pubitemid 30468748)
48. Kälviäinen R, Khyuppenen J, Koskenkorva P, Eriksson K, Vanninen R, Mervaala E, Italiano D, Pezzella M, Coppola A, Magaudda A, Ferlazzo E, Bramanti P, Striano S, Zara F, Striano P,. (2008) Clinical picture of EPM1-Unverricht-Lundborg disease. Epilepsia 49: 549-556. (Pubitemid 351661066)
49. Kammoun F, de Roux N, Boespflug-Tanguy O, Vallée L, Seng R, Tardieu M, Landrieu P,. (2004) Screening of MECP2 coding sequence in patients with phenotypes of decreasing likelihood for Rett syndrome: a cohort of 171 cases. J Med Genet 41: e85.
50. Kankirawatana P, Leonard H, Ellaway C, Scurlock J, Mansour A, Makris CM, Dure LS 4th, Friez M, Lane J, Kiraly-Borri C, Fabian V, Davis M, Jackson J, Christodoulou J, Kaufmann WE, Ravine D, Percy AK,. (2006) Early progressive encephalopathy in boys and MECP2 mutations. Neurology 67: 164-166. (Pubitemid 44305487)
51. Kinirons P, Ibrahim N, Murphy K, Lehesjoki AE, Jarvela I, Delanty N,. (2003) Efficacy of levetiracetam in a patient with Unverricht-Lundborg progressive myoclonic epilepsy. Neurology 60: 1394-1395. (Pubitemid 36461009)
52. Kluwe L, Mautner V, Heinrich B, Dezube R, Jacoby LB, Friedrich RE, MacCollin M,. (2003) Molecular study of frequency of mosaicism in neurofibromatosis 2 patients with bilateral vestibular schwannomas. J Med Genet 40: 109.
53. Kozma SC, Thomas G,. (2002) Regulation of cell size in growth, development and human disease: PI3K, PKB and S6K. BioEssays 24: 65-71. (Pubitemid 34108421)
54. Krueger DA, Care MM, Holland K, Agricola K, Tudor C, Mangeshkar P, Wilson KA, Byars A, Sahmoud T, Franz DN,. (2010) Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N Engl J Med 363: 1801-1811.
55. Laccone F, Junemann I, Whatley S, Morgan R, Butler R, Huppke P, Ravine D,. (2004) Large deletions of the MECP2 gene detected by gene dosage analysis in patients with Rett syndrome. Hum Mutat 23: 234-244. (Pubitemid 38337888)
56. Lamb RF, Roy C, Diefenbach TJ, Vinters HV, Johnson MW, Jay DG, Hall A,. (2000) The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho. Nat Cell Biol 2: 281.
57. Lammert M, Friedman JM, Kluwe L, Mautner VF,. (2005) Prevalence of neurofibromatosis 1 in Germany children at elementary school enrollment. Arch Dermatol 141: 71-74. (Pubitemid 40144442)
58. Ledbetter DH, Rich DC, O'Connell P, Leppert M, Carey JC,. (1989) Precise localization of NF1 to 17q11.2 by balanced translocation. Am J Hum Genet 44: 20.
59. Li MR, Pan H, Bao XH, Zhang YZ, Wu XR,. (2007) MECP2 and CDKL5 gene mutation analysis in Chinese patients with Rett syndrome. J Hum Genet 52: 38-47. (Pubitemid 46020563)
60. Madhavan D, Schaffer S, Yankovsky A, Arzimanoglou A, Renaldo F, Zaroff CM, LaJoie J, Weiner HL, Andermann E, Franz DN, Leonard J, Connolly M, Cascino GD, Devinsky O,. (2007) Surgical outcome in tuberous sclerosis complex: a multicenter survey. Epilepsia 48: 1625.
61. Maezawa I, Swanberg S, Harvey D, LaSalle JM, Jin LW,. (2009) Rett syndrome astrocytes are abnormal and spread MeCP2 deficiency through gap junctions. J Neurosci 29: 5051-5061.
62. Magenis RE, Brown MG, Lacy DA, Budden S, LaFranchi S,. (1987) Is Angelman syndrome an alternate result of del(15)(q11q13)?. Am J Med Genet 28: 829-838. (Pubitemid 17163753)
63. Major P, Thiele EA,. (2008) Vagus nerve stimulation for intractable epilepsy in tuberous sclerosis complex. Epilepsy Behav 13: 357.
64. Moog U, Smeets EE, van Roozendaal KE, Schoenmakers S, Herbergs J, Schoonbrood-Lenssen AM, Schrander-Stumpel CT,. (2003) Neurodevelopmental disorders in males related to the gene causing Rett syndrome in females (MECP2). Eur J Paediatr Neurol 7: 5-12. (Pubitemid 36284838)
65. Moyhuddin A, Baser ME, Watson C, Purcell S, Ramsden RT, Heiberg A, Wallace AJ, Evans DG,. (2003) Somatic mosaicism in neurofibromatosis 2: prevalence and risk of disease transmission to offspring. J Med Genet 40: 459.
66. Muzykewicz DA, Costello DJ, Halpern EF, Thiele EA,. (2009) Infantile spasms in tuberous sclerosis complex: prognostic utility of EEG. Epilepsia 50: 290-296.
67. National Institutes of Health Consensus Development Conference. (1988) Neurofibromatosis conference statement. Arch Neurol, 45: 575-578.
68. Neul JL, Kaufmann WE, Glaze DG, Christodoulou J, Clarke AJ, Bahi-Buisson N, Leonard H, Bailey ME, Schanen NC, Zappella M, Renieri A, Huppke P, Percy AK, RettSearch Consortium. (2010) Rett syndrome: revised diagnostic criteria and nomenclature. Ann Neurol 68: 944.
69. Nordling C,. (1953) A new theory on cancer-inducing mechanism. Br J Cancer 7: 68-72.
70. Pan H, Li MR, Nelson P, Bao XH, Wu XR, Yu S,. (2006) Large deletions of the MECP2 gene in Chinese patients with classical Rett syndrome. Clin Genet 70: 418-419. (Pubitemid 44515645)
71. Parain D, Penniello MJ, Berquen P, Delangre T, Billard C, Murphy JV,. (2001a) Vagal nerve stimulation in tuberous sclerosis complex patients. Pediatr Neurol 25: 213.
72. Pelc K, Boyd SG, Cheron G, Dan B,. (2008) Epilepsy in Angelman syndrome. Seizure 17: 211-217. (Pubitemid 351324161)
73. Pennacchio LA, Lehesjoki AE, Stone NE, Willour VL, Virtaneva K, Miao J, D'Amato E, Ramirez L, Faham M, Koskiniemi M, Warrington JA, Norio R, Dela Chapelle A, Cox DR, Myers RM,. (1996) Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1). Science 271: 1731-1734. (Pubitemid 26102822)
74. Petersen MB, Bŕndum-Nielsen K, Hansen LK, Wulff K,. (1995) Clinical, cytogenetic, and molecular diagnosis of Angelman syndrome: estimated prevalence rate in a Danish county; the disorder predominantly affects Anglo-Saxons. Am J Med Genet 60: 261-262.
75. Rasmussen SA, Friedman JM,. (2000) NF1 gene and neurofibromatosis 1. Am J Epidemiol 151: 33-40. (Pubitemid 30470392)
76. Rett A,. (1966) On a unusual brain atrophy syndrome in hyperammonemia in childhood. Wien Med Wochenschr 116: 723-726.
77. Riikonen R, Simell O,. (1990a) Tuberous sclerosis and infantile spasms. Dev Med Child Neurol 32: 203.
78. Roach E, Sparagana S,. (2004) Diagnosis of tuberous sclerosis complex. J Child Neurol 19: 643-649. (Pubitemid 39530072)
79. Romanelli P, Najjar S, Weiner HL, Devinsky O,. (2002) Epilepsy surgery in tuberous sclerosis: multistage procedures with bilateral or multilobar foci. J Child Neurol 17: 689-692. (Pubitemid 36054406)
80. Rouleau GA, Merel P, Lutchman M, Sanson M, Zucman J, Marineau C, Hoang-Xuan K, Demczuk S, Desmaze C, Plougastel B, Pulst SM, Lenoir G, Bijlsma E, Fashold R, Dumanski J, de Jong P, Parry D, Eldrige R, Aurias A, Delattre O, Thomas G,. (1993) Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 363: 515.
81. Sampson JR, Maheshwar MM, Aspinwall R, Thompson P, Cheadle JP, Ravine D, Roy S, Haan E, Bernstein J, Harris PC,. (1997) Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene. Am J Hum Genet 61: 843-851. (Pubitemid 27418458)
82. Sancak O, Nellist M, Goedbloed M, Elfferich P, Wouters C, Maat-Kievit A, Zonnenberg B, Verhoef S, Halley D, van den Ouweland A,. (2005) Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype-phenotype correlations and comparison of diagnostic DNA techniques in Tuberous Sclerosis Complex. Eur J Hum Genet 13: 731-741. (Pubitemid 40846845)
83. Seizinger BR, Martuza RL, Gusella JF,. (1986) Loss of genes on chromosome 22 in tumorigenesis of human acoustic neuroma. Nature 322: 644.
84. Serratosa JM, Gõmez-Garre P, Gallardo ME, Anta B, de Bernabé DB, Lindhout D, Augustijn PB, Tassinari CA, Malafosse RM, Topcu M, Grid D, Dravet C, Berkovic SF, de Cõrdoba SR,. (1999) A novel protein tyrosine phosphatase gene is mutated in progressive myoclonus epilepsy of the Lafora type (EPM2). Hum Mol Genet 8: 345-352. (Pubitemid 29054277)
85. Shepherd C, Gomez M, Lie J, Crowson C,. (1991) Causes of death in patients with tuberous sclerosis. Mayo Clin Proc 66: 792-796.
86. Side L, Taylor B, Cayouette M, Conner E, Thompson P, Luce M, Shannon K,. (1997) Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders.
87. Steffenburg S, Gillberg CL, Steffenburg U, Kyllerman M,. (1996) Autism in Angelman syndrome: a population-based study. Pediatr Neurol 14: 131.
88. Steffenburg U, Hagberg G, Hagberg B,. (2001) Epilepsy in a representative series of Rett syndrome. Acta Paediatr 90: 34-39. (Pubitemid 32147224)
89. Thiele EA,. (2004) Managing epilepsy in tuberous sclerosis complex. J Child Neurol 19: 680-686. (Pubitemid 39530077)
90. Thiele EA,. (2010) Managing and understanding epilepsy in tuberous sclerosis complex. Epilepsia 51 (Suppl. 1): 90.
91. Trappe R, Laccone F, Cobilanschi J, Meins M, Huppke P, Hanefeld F, Engel W,. (2001) MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin. Am J Hum Genet 68: 1093-1101. (Pubitemid 32424408)
92. Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM, Eldridge R, Kley N, Menon AG, Pulaski K, Haase VH, Ambrose CM, Munroe D, Bove C, Haines JL, Martuza RL, MacDonald ME, Seizinger BR, Short MP, Buckler AJ, Gusella JF,. (1993) A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72: 791.
93. van Baal JG, Smits NJ, Keeman JN, Lindhout D, Verhoef S,. (1994) The evolution of renal angiomyolipomas in patients with tuberous sclerosis. J Urol 152: 35-38. (Pubitemid 24175693)
94. Van Esch H, Bauters M, Ignatius J, Jansen M, Raynaud M, Hollanders K, Lugtenberg D, Bienvenu T, Jensen LR, Gecz J, Moraine C, Marynen P, Fryns JP, Froyen G,. (2005) Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. Am J Hum Genet 77: 442-453. (Pubitemid 41192650)
95. van Slegtenhorst M, de Hoogt R, Hermans C, Nellist M, Janssen B, Verhoef S, Lindhout D, van den Ouweland A, Halley D, Young J, Burley M, Jeremiah S, Woodward K, Nahmias J, Fox M, Ekong R, Osborne J, Wolfe J, Povey S, Snell RG, Cheadle JP, Jones AC, Tachataki M, Ravine D, Sampson JR, Reeve MP, Richardson P, Wilmer F, Munro C, Hawkins TL, Sepp T, Ali JB, Ward S, Green AJ, Yates JR, Kwiatkowska J, Henske EP, Short MP, Haines JH, Jozwiak S, Kwiatkowski DJ,. (1997) Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277: 805.
96. Venancio M, Santos M, Pereira SA, Maciel P, Saraiva JM,. (2007) An explanation for another familial case of Rett syndrome: maternal germline mosaicism. Europ J Hum Genet 15: 902-904. (Pubitemid 47109052)
97. Verhoef S, Bakker L, Tempelaars AM, Hesseling-Janssen AL, Mazurczak T, Jozwiak S, Fois A, Bartalini G, Zonnenberg BA, van Essen AJ, Lindhout D, Halley DJ, van den Ouweland AM,. (1999) High rate of mosaicism in tuberous sclerosis complex. Am J Hum Genet 64: 1632.
98. Vivarelli R, Grosso S, Calabrese F, Farnetani M, Di Bartolo R, Morgese G, Balestri P,. (2003) Epilepsy in neurofibromatosis 1. Child Neurol 18: 338-342. (Pubitemid 36798348)
99. Weaving LS, Christodoulou J, Williamson SL, Friend KL, McKenzie OL, Archer H, Evans J, Clarke A, Pelka GJ, Tam PP, Watson C, Lahooti H, Ellaway CJ, Bennetts B, Leonard H, Gecz J,. (2004) Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation. Am J Hum Genet 75: 1079-1093. (Pubitemid 39532075)
100. Weaving LS, Ellaway CJ, Gecz J, Christodoulou J,. (2005) Rett syndrome: clinical review and genetic update. J Med Genet 42: 1-7. (Pubitemid 40187114)
101. Webb DW, Fryer AE, Osborne JP,. (1991) On the incidence of fits and mental retardation in tuberous sclerosis. J Med Genet 28: 395.
102. Webb DW, Fryer AE, Osborne JP,. (1996) Morbidity associated with tuberous sclerosis: a population study. Dev Med Child Neurol 38: 146.
103. Weiner DM, Ewalt DH, Roach ES, Hensle TW,. (1998) The tuberous sclerosis complex: a comprehensive review. J Am Coll Surg 187: 548-561. (Pubitemid 28506864)
104. Wieland I, Jakubiczka S, Muschke P, Cohen M, Thiele H, Gerlach KL, Adams RH, Wieacker P,. (2004) Mutations of the ephrin-B1 gene cause craniofrontonasal syndrome. Am J Hum Genet 74: 1209-1215. (Pubitemid 38669319)
105. Wienecke R, König A, DeClue JE,. (1995) Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap1GAP activity. J Biol Chem 270: 16409.
106. Wilfong AA, Schultz RJ,. (2006) Vagus nerve stimulation for treatment of epilepsy in Rett syndrome. Dev Med Child Neurol 48: 683-686. (Pubitemid 44044473)
107. Williams CA, Beaudet AL, Clayton-Smith J, Knoll JH, Kyllerman M, Laan LA, Magenis RE, Moncla A, Schinzel AA, Summers JA, Wagstaff J,. (2006) Angelman syndrome 2005: updated consensus for diagnostic criteria. Am J Med Genet A 140: 413-418. (Pubitemid 43376311)
108. Williams CA, Driscoll DJ, Dagli AI,. (2010) Clinical and genetic aspects of Angelman syndrome. Genet Med 12: 385-395.
109. Willmore LJ, Abelson MB, Ben-Menachem E, Pellock JM, Shields WD,. (2009) Vigabatrin: 2008 update. Epilepsia 50: 163-173.
110. Zahorakova D, Rosipal R, Hadac J, Zumrova A, Bzduch V, Misovicova N, Baxova A, Zeman J, Martasek P,. (2007) Mutation analysis of the MECP2 gene in patients of Slavic origin with Rett syndrome: novel mutations and polymorphisms. J Hum Genet 52: 342-348. (Pubitemid 46496295)
111. Zamponi N, Petrelli C, Passamonti C, Moavero R, Curatolo P,. (2010) Vagus nerve stimulation for refractory epilepsy in tuberous sclerosis. Pediatr Neurol 43: 29.
112. Zhang Y, Minassian BA,. (2008) Will my Rett syndrome patient walk, talk, and use her hands?. Neurology 70: 1302-1303. (Pubitemid 351550336)
113. Zöller MET, Rembeck B, Odén A, Samuelsson M, Angervall L,. (1997) Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population. Cancer, 79: 2125-2131. (Pubitemid 27227376)